X
Novartis/Amgen migraine jab works in tough-to-treat patients
https://pharmaphorum.com/news/novartis-amgen-migraine-jab-works-tough-treat-patients/
Eli Lilly
Trulicity helps SGLT-2 patients lower blood sugar
New phase 3b trial results show Lilly’s Trulicity combined with an SGLT2 inhibitor failed to show any benefits above and beyond Trulicity’s blood glucose lowering.
Novo’s GLP-1 duel with Lilly begins as drug reimbursed in US
Oral formulation succeeds in first phase 3 trial
Lilly axes trial of Hanmi’s arthritis drug
Lilly may decide to develop drug in other indications
South Korea hopes big data will boost life sciences industry
South Korea is to build a comprehensive database of genetic and biometric data from 10 million people, in a bid to boost its pharma and biotech industry.
Doubts over BACE drugs after Merck ends Alzheimer’s trial
Decision comes a year after Merck axed EPOCH verubecestat trial
